Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bioactive preparation based on tumor cell membrane, and preparation method and application thereof

A bioactive, cell membrane technology, applied in the field of medicine, to achieve the effect of inhibiting the production of tumor exosomes, improving the anti-tumor effect in vivo, and having less toxic and side effects

Active Publication Date: 2021-08-27
SHANDONG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no drug that can directly target exosomal PD-L1 in clinical practice, thus presenting a challenge for the precise regulation of exosomal PD-L1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bioactive preparation based on tumor cell membrane, and preparation method and application thereof
  • Bioactive preparation based on tumor cell membrane, and preparation method and application thereof
  • Bioactive preparation based on tumor cell membrane, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0060] In yet another specific embodiment of the present invention, a method for preparing the above-mentioned cell membrane-based bioactive preparation is provided, including:

[0061] The tumor cell membrane modified by sodium alginate oxide forms a gel factor, and the CDK5 inhibitor and the exosome inhibitory drug are respectively dissolved and mixed uniformly to form a drug solution, which is added to the aqueous solution of the gel factor and stirred to obtain a gelling solution.

[0062] In yet another specific embodiment of the present invention, the solvent for dissolving the CDK5 inhibitor and the exosome inhibitor is deionized water, which has a better dissolving effect, and the method of adding the drug solution is dropwise, so that the antitumor drug components are more dispersed uniform;

[0063] In yet another specific embodiment of the present invention, the cell membrane vesicles are prepared by the following method:

[0064] (1) Collect mouse tumor tissue, an...

Embodiment 1

[0095] Example 1: Preparation of tumor cell membrane vesicles modified by sodium alginate oxide

[0096] 1) Preparation of tumor single cell suspension: After collecting mouse melanoma tissue, it was obtained by adding homogenization buffer and then grinding. The homogenization buffer contained 0.25mM sucrose, 1mM EDTA, 20mM HEPES-NaOH and protease inhibitor Reagent PBS buffer.

[0097] 2) Extraction of tumor cell membrane: The collected tumor single-cell suspension was subjected to probe ultrasound at 4°C to break the tumor cells to obtain broken tumor cells. The power amplitude of the probe ultrasound was 40%, the time was 10min, and the interval was 4s. Off: 2s; Centrifuge the broken tumor cells at 3000g for 10min at 4°C to remove melanin for purification; centrifuge the purified broken cell suspension at 15000g for 60min at 4°C to obtain tumor cell membrane pellets; redisperse the cell membrane pellets In PBS, cryopreserved.

[0098] 3) Preparation of tumor cell membrane...

Embodiment 2

[0101] Example 2: Transmission electron microscopy (TEM) identification of nanostructures of tumor cell membrane vesicles before and after modification

[0102] Use a pipette gun to draw 10 μL of the tumor cell membrane vesicle solution before and after modification, carbon film copper grid, and filter paper to absorb excess liquid, dry it at room temperature, and observe it under a transmission electron microscope. The result is as figure 1 As shown in the transmission electron microscope pictures, it can be confirmed that the morphology of the tumor cell membrane vesicles before and after the modification is significantly different, and the sizes are ~160 and ~200nm respectively, and the size is uniform and the dispersion is good.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a bioactive preparation based on a tumor cell membrane, and a preparation method and application thereof, and belongs to the technical field of medicines. Tumor tissue of a tumor-bearing mouse is extracted and processed to form tumor cell membrane vesicles, the tumor cell membrane vesicles are chemically modified to form a gelator capable of forming gel in situ in the tumor tissue, and after a cyclin dependent kinase 5 (CDK5) inhibitor and an exosome inhibitor are co-loaded, tumor cells and tumor exosomes PD-L1 can be effectively regulated and controlled, local and systemic immunosuppression is relieved at the same time, and the bioactive preparation has a good practical application value.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a tumor cell membrane-based biologically active preparation and a preparation method and application thereof. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Programmed death 1 ligand (PD-L1) is generally considered to act on the surface of tumor cells, however, the failure rate of PD-L1 blockade-based immunotherapy remains high in clinical cases. Current approaches to enhance the response efficiency of PD-L1-based therapies are limited to local modulation of the tumor site, such as increasing tumor immunogenicity and remodeling the tumor immune microenvironment, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K47/61A61K47/69A61K9/06A61P35/00A61P37/04
CPCA61K45/06A61K9/06A61K47/61A61K47/6901A61P35/00A61P37/04
Inventor 栾玉霞李倩
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com